Frontlight ResearchEarly access
Trial site
Cluj-Napoca
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia2 trials
- Childhood cancers1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Rheumatoid arthritis1 trial
- Sjögren's disease1 trial
- Stroke1 trial
- Phase
- Phase 32 trials
- Phase 11 trial
- Phase 21 trial
- Phase 41 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals5 trials
Running trials
Active, not recruiting
An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Closed trials
Completed
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026